Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-03-10 5:03 pm Purchase | 13G | CTI BIOPHARMA CORP CTIC | ORBIMED ADVISORS LLC | 9,520,000 12.9% | 4,520,000 (+90.40%) | View |
| 2020-03-04 5:29 pm Unchanged | 13D | CTI BIOPHARMA CORP CTIC | BIOTECHNOLOGY VALUE FUND L P | 12,753,690 19.99% | 0 (Unchanged) | View |
| 2020-02-13 4:32 pm Sale | 13G | CTI BIOPHARMA CORP CTIC | Stonepine Capital Management LLC | 3,613,600 6.2% | -2,112,979 (-36.90%) | View |
| 2020-02-13 10:46 am Unchanged | 13D | CTI BIOPHARMA CORP CTIC | Growth Equity Opportunities V LLC | 3,750,000 6.5% | 0 (Unchanged) | View |
| 2020-02-04 5:22 pm Sale | 13D | CTI BIOPHARMA CORP CTIC | BIOTECHNOLOGY VALUE FUND L P | 12,753,690 19.99% | -206 (-0.00%) | View |